Austar Lifesciences Limited 6118.HK Stock
Austar Lifesciences Limited Price Chart
Austar Lifesciences Limited 6118.HK Financial and Trading Overview
Austar Lifesciences Limited stock price | 1.16 HKD |
Previous Close | 1.91 HKD |
Open | 1.83 HKD |
Bid | 2 HKD x 0 |
Ask | 2.01 HKD x 0 |
Day's Range | 1.83 - 2 HKD |
52 Week Range | 1.27 - 2.96 HKD |
Volume | 785K HKD |
Avg. Volume | 227.03K HKD |
Market Cap | 1.03B HKD |
Beta (5Y Monthly) | 1.093869 |
PE Ratio (TTM) | 10 |
EPS (TTM) | -0.06 HKD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | May 19, 2015 |
1y Target Est | N/A |
6118.HK Valuation Measures
Enterprise Value | 1.15B HKD |
Trailing P/E | 10 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.4599945 |
Price/Book (mrq) | 1.1428572 |
Enterprise Value/Revenue | 0.518 |
Enterprise Value/EBITDA | 10.88 |
Trading Information
Austar Lifesciences Limited Stock Price History
Beta (5Y Monthly) | 1.093869 |
52-Week Change | -22.67% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.96 HKD |
52 Week Low | 1.27 HKD |
50-Day Moving Average | 1.9 HKD |
200-Day Moving Average | 1.88 HKD |
6118.HK Share Statistics
Avg. Volume (3 month) | 227.03K HKD |
Avg. Daily Volume (10-Days) | 59.8K HKD |
Shares Outstanding | 512.58M |
Float | 131.88M |
Short Ratio | N/A |
% Held by Insiders | 73.53% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 3.92% |
Operating Margin (ttm) | 4.05% |
Gross Margin | 20.76% |
EBITDA Margin | 4.75% |
Management Effectiveness
Return on Assets (ttm) | 2.54% |
Return on Equity (ttm) | 8.10% |
Income Statement
Revenue (ttm) | 2.23B HKD |
Revenue Per Share (ttm) | 4.35 HKD |
Quarterly Revenue Growth (yoy) | -3.00000000000000000000000000000000% |
Gross Profit (ttm) | 462.67M HKD |
EBITDA | 106.07M HKD |
Net Income Avi to Common (ttm) | 87.46M HKD |
Diluted EPS (ttm) | 0.2 |
Quarterly Earnings Growth (yoy) | -30.00000000000000000000000000000000% |
Balance Sheet
Total Cash (mrq) | 148.13M HKD |
Total Cash Per Share (mrq) | 0.29 HKD |
Total Debt (mrq) | 336.54M HKD |
Total Debt/Equity (mrq) | 38.09 HKD |
Current Ratio (mrq) | 1.324 |
Book Value Per Share (mrq) | 1.75 |
Cash Flow Statement
Operating Cash Flow (ttm) | -37926000 HKD |
Levered Free Cash Flow (ttm) | -200181376 HKD |
Profile of Austar Lifesciences Limited
Country | Hong Kong |
State | N/A |
City | Shanghai |
Address | Rooms 2010-2013 |
ZIP | N/A |
Phone | 86 40 0812 1586 |
Website | https://www.austar.com.hk |
Industry | Medical Devices |
Sector(s) | Healthcare |
Full Time Employees | 1913 |
Austar Lifesciences Limited, an investment holding company, engages in the provision of integrated engineering solutions to pharmaceutical manufacturers and research institutes in Mainland China and internationally. It operates through six segments: Liquid and Bioprocess System; Clean Room and Automation Control and Monitoring System; Powder and Solid System; GMP Compliance Service; Life Science Consumables; and Distribution and Agency of Pharmaceutical Equipment. The company offers liquid and bioprocess systems, including pharmaceutical water, and liquid preparation and bioprocess systems; clean room enclosure, automation control and monitoring systems; and freeze-dryer, sterile filling, and visual inspection equipment, as well as clean utility, powder, and solid equipment and systems. It also provides pharmaceutical process contamination control products; packaging and aseptic containment products; biosafety and lab animal equipment and consumables; laboratory one-stop solutions; and single-use bioprocess equipment and consumables. In addition, the company offers pharmaceutical engineering design, consulting, process technology, facility operations and maintenance, laboratory and digitalization construction, quality risk control, and research and development services. Further, it is involved in the agency and distribution of pharmaceutical equipment, as well as provides contract execution, assembly and pre-assembly, and GMP compliance services. The company was founded in 1991 and is headquartered in Shanghai, China.
Q&A For Austar Lifesciences Limited Stock
What is a current 6118.HK stock price?
Austar Lifesciences Limited 6118.HK stock price today per share is 1.16 HKD.
How to purchase Austar Lifesciences Limited stock?
You can buy 6118.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Austar Lifesciences Limited?
The stock symbol or ticker of Austar Lifesciences Limited is 6118.HK.
Which industry does the Austar Lifesciences Limited company belong to?
The Austar Lifesciences Limited industry is Medical Devices.
How many shares does Austar Lifesciences Limited have in circulation?
The max supply of Austar Lifesciences Limited shares is 512.58M.
What is Austar Lifesciences Limited Price to Earnings Ratio (PE Ratio)?
Austar Lifesciences Limited PE Ratio is now.
What was Austar Lifesciences Limited earnings per share over the trailing 12 months (TTM)?
Austar Lifesciences Limited EPS is -0.06 HKD over the trailing 12 months.
Which sector does the Austar Lifesciences Limited company belong to?
The Austar Lifesciences Limited sector is Healthcare.